- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02638025
Anterior Segment Spectral-domain Optical Coherence Tomography in Patients With Closed Globe Injury
December 20, 2015 updated by: Huizhou Municipal Central Hospital
This study use anterior segment spectral-domain optical coherence tomography (SD-OCT) to exam patients with closed globe injury, and compared with slit lamp examination.
The results showed that OCT can identify features of closed globe injury that were otherwise not visible on slit lamp biomicroscopy.
Study Overview
Detailed Description
The anterior segment architecture changes of closed globe injury patients include corneal damage, hyphema, angle recession and lens dislocation, which can be showed with OCT.
OCT was superior to slit lamp biomicroscopy examination in detecting anterior segment architecture changes, especially in the presence of media opacities.
Study Type
Observational
Enrollment (Actual)
16
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients with closed globe injury were recruited, and all eyes of recruited patients had hyphema occupying at least 1/3rd of anterior chamber volume
Description
Inclusion Criteria:
- patients with closed globe injury were recruited; had hyphema at least 1/3 of anterior chamber volume
Exclusion Criteria:
- can not cooperate with examination
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
anterior segment spectral-domain optical coherence tomography (SD-OCT) findings in patients with closed globe injury
Time Frame: within 24 hours after patients were admitted
|
within 24 hours after patients were admitted
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
July 1, 2011
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
December 16, 2015
First Submitted That Met QC Criteria
December 20, 2015
First Posted (Estimate)
December 22, 2015
Study Record Updates
Last Update Posted (Estimate)
December 22, 2015
Last Update Submitted That Met QC Criteria
December 20, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HMCH20151216
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eye Injuries
-
Ministry of Health, MalaysiaUnknown
-
Shahid Beheshti University of Medical SciencesUnknownEye BurnsIran, Islamic Republic of
-
Vienna Institute for Research in Ocular SurgeryTerminatedEye DiseasesAustria
-
Lundquist Institute for Biomedical Innovation at...Unknown
-
Pamukkale UniversityCompletedOther and Unspecified Superficial Injuries of Eye
-
Sun Yat-sen UniversityUnknown
-
The Baruch Padeh Medical Center, PoriyaRambam Health Care Campus; Soroka University Medical CenterWithdrawn
-
Moorfields Eye Hospital NHS Foundation TrustCompletedEye Injury TraumaUnited Kingdom
-
Santen Inc.Vistakon PharmaceuticalsTerminatedCorneal TransplantationUnited States
Clinical Trials on OCT
-
Assiut UniversityNot yet recruitingProliferative Diabetic Retinopathy
-
University of ZurichUnknownGlaucoma | CataractSwitzerland
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Careggi HospitalCompletedCoronary Artery | Stent Thrombosis | Platelet | ThrombusItaly
-
University Hospital Inselspital, BerneRecruitingGlaucoma | Macular Degeneration | Uveitis | Diabetic Retinopathy | Diabetic Macular Edema | Macular Edema | Retinal Vein Occlusion | Optic Nerve Diseases | Retinal Detachment | Macular Disease | Retinal Disease | Retinal Neovascularization | Retinal Artery Occlusion | Hypertensive Retinopathy | Retinal Edema | Retinal DystrophySwitzerland
-
Topcon Medical Systems, Inc.Completed
-
Topcon CorporationCompletedFluorescein Angiography ImagingUnited States
-
Centre Hospitalier Intercommunal CreteilWithdrawn